109P Efficacy of first-line immune-based combined systemic therapy and brain radiotherapy in patients with brain metastases (BM) from driver gene-negative NSCLC
and comparisons were made between the two groups in terms of objective response rate (ORR), disease control rate (DCR), progression-free survival (PFS), overall survival (OS), and the incidence of adverse events (AEs).
Authors
- Puyuan Xing (ORCID: https://orcid.org/0000-0003-4415-9892)
- Lijun Wu (ORCID: https://orcid.org/0000-0002-5005-6403)
- Min You
- Jianmin Liu (ORCID: https://orcid.org/0000-0002-3599-8267)
- Xu Hao
- J. Li (ORCID: https://orcid.org/0009-0002-7498-1393)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Immuno-Oncology Technology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1016/j.iotech.2024.100852
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00